McKesson Subpoenaed By N.Y. Attorney General
This article was originally published in The Pink Sheet Daily
Executive Summary
McKesson has received a subpoena from the New York Attorney General seeking information related to the "secondary" pharmaceutical wholesale market, the company said in an April 8 filing with the Securities & Exchange Commission
You may also be interested in...
N.Y. Attorney General Seeks Information On Wholesaler Deals With Secondary Market
Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.